The aberrant expression of TNFR2 or enrichment of TNFR2-positive immune-suppressive cell types, such as Tregs and MDSCs, in the tumor microenvironment (TME) may contribute to the evasion of tumor cells from the immune system. Here, TNFRSF1B is linked to neoplasm.